Announcement on Resolutions of the 16th Session of the Ninth Board of Directors
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviation: Jianfeng Group No.: Pro 2017-034
Bond Abbreviation: 13 Peak 01 Bond Code: 122227
Bond Abbreviation: 13 Peak 02 Bond Code: 122344
Zhejiang Jianfeng Group Co., Ltd.
9th 16th Board Resolution Announcement
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and shall bear individual and joint liability for the authenticity, accuracy and completeness of its contents.
1. Board Meeting
(I) The convening and convening of this board meeting complies with relevant laws, regulations and the company's "Articles of Association.
(II) 2017# On October 19, 29, the company issued the notice of the board meeting by fax, e-mail and personal delivery.
(III) 2017On October 30, the board meeting was held by means of communication voting.
(IV) 9directors who should attend this board meeting, 9 directors who actually attended the meeting, and 9 valid votes at the meeting.
Review of 2. Board Meeting(I) Passed "2017
Third Quarter Report"
After deliberation and voting, the Board of Directors passed "Company 2017Third Quarter Report".
Voting result: 9votes in favor, 0 votes against, 0 abstentions. The third quarter report of
company 2017can be found on the website of Shanghai Stock Exchange (www.sse.com.cn).
(II) passed the "Proposal on the General Election of the Board of Directors"The current board of directors was elected at the first extraordinary general meeting of shareholders in 2014 held on November 12, 2014
. The term of office of the board of directors is three years, and a general election is required. The company's largest shareholder, Jinhua Tongji State-owned Assets Investment Company, recommended Mr. Jiang Xiaomeng, Mr. Yu Jianhong, Mr. Liu Bo, and Mr. Zhang Guoping as candidates for the company's tenth board of directors; the current board of directors recommended: Mr. Du Zihong, Mr. Huang Sujian, Shi Ximin Mr., Mr. Huang Congyun, Mr. Sun Hongbin are candidates for the company's tenth board of directors, among them, Mr. Shi Ximin, Mr. Huang Conyun, and Mr. Sun Hongbin are candidates for independent directors (the candidates' resumes are attached); the above 9 persons will be submitted as candidates for the company's tenth board of directors to the first extraordinary general meeting of shareholders in 2017. The general meeting of shareholders will provide online voting, and the cumulative voting system will not be adopted to elect directors. Each director candidate will be proposed in the form of a single proposal. According to the company's "Articles of Association", the current directors will continue to perform their duties as directors until a new board of directors is elected by the general meeting of shareholders.
The three independent directors of the company expressed their independent opinions on this and agreed to the proposal on the change of the board of directors passed at the meeting. At the same time, they believed that the formation of the above resolutions complied with the relevant provisions of the Company Law and the Company's Articles of Association, and did not harm small and medium shareholders. interest.After deliberation and voting, the board of directors passed the "Proposal on the General Election of the Board of Directors."
Voting result: 9
votes in favor, 0 votes against, 0 abstentions.
(III) passed the "Proposal on Convening the First Extraordinary General Meeting of Shareholders in 2017"
. After deliberation and voting, the board of directors passed the proposal and agreed to issue a notice. The company's first extraordinary general meeting of shareholders in 2017 will be held on November 16, 2017to hold a general election for the board of directors and the board of supervisors of the company. Voting result of
: 9votes in favor, 0 votes against and 0 abstentions. For details of
, please refer to the Company's Notice on Convening the First Extraordinary General Meeting of Shareholders in 2017(P.2017 -037).
3. Internet Announcement Annex1
, Independent Director Opinions of the 9th Independent Director of the Company on the Above Related Matters.
2, Independent Director Candidate Statement.
3, Independent Director Nominee Statement.
hereby announcesZhejiang Jianfeng Group Co., Ltd.
Board of Directors
October 31, 2017Attached: Resume of Director Candidate
1
, Mr. Jiang Xiaomeng: 1964# born in November 117, master of Business Administration/Engineering, professor-level senior engineer, licensed pharmacist, expert enjoying special allowance of the State Council, young and middle-aged expert with outstanding contribution in Zhejiang Province, joined the work in December 1980, successively served as workshop director of Jinhua cement Plant, manager of enterprise management department of the company, general manager of Zhejiang Jianfeng Communication Cable Co., Ltd., general manager of Zhejiang Jianfeng Pharmaceutical Co., Ltd., deputy general manager and general manager of the company. He is currently the Chairman and Secretary of the Party Committee of the Company, concurrently serving: vice Chairman of the Board of Directors of Tianshili Holding Group Co., Ltd., Vice Chairman of Tianshili Pharmaceutical Group Co., Ltd., Director of Southern Cement Co., Ltd., Chairman of Zhejiang Jinhua Nanfang Jianfeng Cement Co., Ltd., Director of Jinhua Tongji State-owned Assets Investment Co., Ltd., Zhejiang Building Materials Industry Chairman, Vice President of Zhejiang Chamber of Commerce, Vice President of Zhejiang Entrepreneurs Association, Chairman of Jinhua Federation of Industry and Commerce, Chairman of Jinhua General Chamber of Jinhua Entrepreneurs Association. 2
, Mr. Du Zihong: 1939# born in December 121, senior economist, joined the work in December 1957, served as the director of Jinhua Cement Plant since 1983, and later served as the company's general manager, Chairman and Secretary of the Party Committee. He is currently a director of the company and concurrently serves as a director of Tianshili Holding Group Co., Ltd. and vice chairman of China Enterprise Management Research Association.3 , Mr. Yu Jianhong: born in October 125, 1966#, senior economist, engineer, EMBA, joined the work in September 1987, successively served as deputy director of the machine repair workshop of Jinhua cement factory, chief of technical department, deputy director and director of Jinsong cement factory, general manager of Jianfeng group Jinhua Jinma cement co., ltd., general manager of Zhejiang Jianfeng cement co., ltd., deputy general manager of the company, and currently the director and general manager of the company, part-time: Vice President of Zhejiang Cement Association.
4 , Mr. Huang Sujian: 1955# born in November 129, doctor of economics, researcher, worked in the Institute of Industrial Economics of the Chinese Academy of Social Sciences from February 1988 to April 2016, and served as the Deputy Director of the Institute of Industrial Economics of the Chinese Academy of Social Sciences. He is currently a director of the company, a researcher at the Institute of Industrial Economics of the Chinese Academy of Social Sciences, and the president of the China Enterprise Management Research Association. He is also an independent director of Inner Mongolia Yitai Coal Co., Ltd., an independent director of Wolong Electric Group Co., Ltd., and an independent director of Zhejiang China Commodity City Group Co., Ltd.
5, Mr. Liu Bo: 1974# born in November 133, bachelor's degree, lecturer, took part in the work in August 1997. He used to be a teacher of Jinhua Radio and Television University, deputy director of the student office, director and vice president of the party committee president's office, and deputy general manager of Jinhua Tongji State-owned Assets Investment Co., Ltd. The current legal representative of Jinhua Tongji State-owned Assets Investment Co., Ltd. and deputy general manager of Jinhua State-owned Assets Management Co., Ltd. 6
, Mr. Zhang Guoping: 1976# born in June 137, bachelor degree, economist, started work in March 1999, assistant to the general manager and deputy director of the transportation department, assistant to the general manager and deputy director of the transportation department, director of the transportation department, and assistant to the manager and director of the office of Jinhua urban and, manager of Science and Technology Information Department of Jinhua Public Transport Group Co., Ltd., Assistant General Manager of Jinhua Asset Management Co., Ltd., Deputy General Manager of Jinhua Asset Management Co., Ltd.7 , Mr. Shi Ximin: 1960# was born in June 141, Ph.D. in management (accounting), currently an independent director of the company, a professor at the School of Accounting of Zhejiang University of Finance and Economics, and concurrently an independent director of Wolong Real Estate Group Co., Ltd., Zhejiang Feida Environmental Protection Technology Co., Ltd., Zhejiang Jiangshan Chemical Co., Ltd., Haining China Leather City Co., Ltd.
8 , Mr. Huang Congyun: 1963# born in March 145, professor and doctoral supervisor, currently professor of the School of Materials Science and Engineering of Wuhan University of Technology, professor of the State Key Laboratory of Silicate Building Materials. Expert member of the National Cement Standardization Technical Committee, deputy director of the Expert Technical Committee of China Cement Grinding Aids Association. He is now an expert in the evaluation of the National Science and Technology Progress Award and the Technology Invention Award, and an expert in the evaluation of various funds in Hubei, Shandong, Chongqing and other provinces and cities. As "cement grinding aids and concrete admixture", "cement equipment technology" and "cement additives" magazine consultant. Member of the Hubei Provincial Committee of the Democratic National Construction Association, Chairman of the Committee of the Wuhan University of Technology of the Democratic National Construction Association. He is currently an independent director of the Company.
9, Mr. Sun Hongbin: 1966# Born in December 149, Doctor of Science, Distinguished Professor of "Changjiang Scholar" of the Ministry of Education. He has successively engaged in post-doctoral research in Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Aachen University of Technology in Germany and University of Florida in the United States, and engaged in new drug research in California Metabolex Company in the United States. He is currently an independent director of the Company, a professor, doctoral supervisor and director of the New Drug Research Center of China Pharmaceutical University, director of Jiangsu Provincial Key Laboratory of Metabolic Diseases, Deputy Director of State Key Laboratory of "Natural Drug Active Components and Efficacy", Member of Medicinal Chemistry Professional Committee of Chinese Pharmaceutical Association, Deputy Chairman of Medicinal Chemistry Professional Committee of Jiangsu Pharmaceutical Association, Member of Degree Evaluation Committee and Academic Committee of China Pharmaceutical University, Deputy Leader of the "Thirteenth Five-Year" Development Strategy Research "Pharmacology" Expert Group of the Medical Department of the National Fund Committee, National Technology Invention Award Meeting Review Expert, Honorary Jiangsu Weikair chairman, etc.
More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31